Dermata Therapeutics Inc (DRMA) Quote

silly mover

DRMA just halted to upside

These bots are ruthless

DRMA..........................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783

Cha ching

Too funny

Whoops, I did it, again

Get your life jacket on

Hahahahahah

I must be dreaming!

LOL

New lows

DRMA new 52 week low

DRMA under $2

Yawn…

$DRMA 562,000 O/S and traded over a mil today..

DRMA........................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783

Let me know when

Reverse split completed watch for new bottom

DRMA new 52 lo

DRMA...............................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783

DRMA10QnduebMarchb6

DRMA.................................https://stockcharts.com/h-sc/ui?s=DRMA&p=W&b=5&g=0&id=p86431144783

Might have a good AH again.

DRMA: And when all is said & done, a classic TOILET FLUSH!!! (Heck with this shit, I'm goin' back to Vegas!!)

Yep I'm well. Same to you as well.

Gonna try to jump in here in the AM if it don't get too far gone.

Thank you, buddy! Hope you're doing well and happy new year!

Absolutely, nice move here.

Win or loose I had to take a shot. You know me well lol

NICE BUYS, BETTER LATE THAN NEVER

Zorro just filled at $1.12 now gonna sleep on it lol

Nothing makes sense anymore! Most of the Pink Sheets have no liquidity anymore. This BS on the NASDAQ is the only game of chance lol

I'm jumping in now

Must be time to buy:
https://www.barchart.com/stocks/quotes/DRMA/opinion

GOOD ALERT ON NEWS, THE CHART IS A PRIME EXAMPLE OF HOW CRAZY THIS MARKET REALLY IS

https://finviz.com/quote.ashx?t=DRMA&ty=c&ta=1&p=d

Nice catch!

Lol! Scared money doesn't make any. Sometimes you just have to go with your instincts.

DRMAW (Warrants): Closed UP by 153% today in the OPEN Market --- before the Post-M news even hit (Insiders at work).

I have to think a good chunk of that 7 million offering got bought. I'm thinking about taking a slice on a dip because IMHO this could fly past $2.00 tomorrow. Total game of craps but I'm a compulsive gambler :)

Always the guess with AH. Dang MM like to play early PM.

This baby is flying to new heights! Will be interesting how she does tomorrow

Might have more gas in the tank.

Made some nice money on the warrants if they sold.

Here you go, buddy https://www.otcmarkets.com/filing/html?id=17107805&guid=eyJ-kpcUPOVAB3h

Thanks! At what price if you know. OVER 7m just traded.

I used to trade this one. Haven't seen it in a while. There is an offering for 7.1 million shares

Was wondering why it was moving. Low floater 3.54M worth keeping an eye on.. Thanks for posting.

NEWS
Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis
- This is the Company's first patent issued for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -
- The Company is currently discussing partnership opportunities to advance development of DMT410 -
- In 2022, the Japanese prevalence of hyperhidrosis was 10%, with approximately 6% having primary axillary hyperhidrosis -

SAN DIEGO, CA / ACCESSWIRE / January 4, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. The patent, entitled "Compositions for the treatment of skin conditions," (Japanese Patent No. 7395576) further strengthens Dermata's intellectual property for DMT410 for the treatment of hyperhidrosis and could lead to further protections for additional indications.

"We believe this patent issuance further validates DMT410's novel concept to easily deliver botulinum toxin topically instead of requiring patients to receive multiple injections," says Gerry Proehl, Dermata's Chairman, President, and CEO. "We are excited about the opportunities the DMT410 program can bring to patients, not only for the treatment of axillary hyperhidrosis as we have seen in our proof-of-concept study, but potentially for palmer and plantar hyperhidrosis which has no currently approved products. We also believe there are opportunities to use DMT410 to treat many aesthetic skin conditions like reducing pore number and size, decreasing sebum production, and reducing fine lines and wrinkles, all while improving the look and quality of facial skin," continued Mr. Proehl. "We also believe this new patent could aid us in our partnership discussions with a company that has a botulinum toxin to further develop the DMT410 program for multiple indications."

About DMT410

$DRMA rolling in A/Hs.

https://www.otcmarkets.com/stock/DRMA